The data thus provide a strong mechanistic rationale for therapeutic inhibition of Nox4 as a stromal‐targeted approach to complement current treatment strategies for PCa and restore dysregulated reciprocal stromal–epithelial interactions. Here, NOX4 is linked to posterior cortical atrophy.